Atlas Trials

Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)

Clinical trial NCT05647278 · COMPLETED

Trial details

NCT number
NCT05647278
Sponsor
Zhang Xiaofeng,MD
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Helicobacter Pylori Infection
Start date
2023-11-01
Primary completion
2025-09-30
Enrollment
370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.